A Study to Evaluate the Safety and Efficacy of Tazarotene Foam, 0.1%, in Subjects With Common Facial Acne
Clinical trial NCT01017120 · COMPLETED
Trial details
- NCT number
- NCT01017120
- Sponsor
- Stiefel, a GSK Company
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2009-10-01
- Primary completion
- 2010-11-01
- Enrollment
- 742
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.